Shalby logo

SHALBY - Shalby Share Price

₹107.35 -2.5  -2.3%

Last Trade - 3:45am

Small Cap
Market Cap £115.9m
Enterprise Value £110.2m
Revenue £38.6m
Position in Universe 749th / 3056
Unlock SHALBY Revenue
Relative Strength (%)
1m -5.31%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -18.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2,754 2,904 3,238 3,780 4,623 4,869 4,145 5,262 +12.1%
-34.1 +46.0 -21.3 +35.2 -20.7 -12.8 +73.9 +7.87
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, ShalbyLtd revenues decreased 24% to RS2.86B. Net income decreased27% to RS325.9M. Revenues reflect a decrease in demand forthe Company's products and services due to unfavorablemarket conditions. Net income also reflects Depreciationand amortisation expenses increase of 2% to RS274.2M(expense), Other income decrease of 5% to RS69.3M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


SHALBY Revenue Unlock SHALBY Revenue

Net Income

SHALBY Net Income Unlock SHALBY Revenue

Normalised EPS

SHALBY Normalised EPS Unlock SHALBY Revenue

PE Ratio Range

SHALBY PE Ratio Range Unlock SHALBY Revenue

Dividend Yield Range

SHALBY Dividend Yield Range Unlock SHALBY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SHALBY EPS Forecasts Unlock SHALBY Revenue
Profile Summary

Shalby Limited operates a multi-specialty chain of hospitals. Its hospitals are tertiary care hospitals, which offer quaternary healthcare services. It provides services to a range of specialization, including orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. The Company focuses on focus on Tier-I and Tier-II cities. Its hospitals operate across five states. Its outpatient clinic operates across 53 cities in 16 states in India, and Shalby Arthroplasty Centre of Excellence (SACE) in five cities in four states in India. The Company’s international footprint includes six outpatient clinics and one SACE in Africa, and two SACE in the United Arab Emirates. It provides inpatient and outpatient consultative services through 11 hospitals, having a aggregate operational bed capacity of approximately2,012 beds. It also provides outpatient services through approximately 68 clinics and eight shared surgery centers within third party hospitals.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated August 30, 2004
Public Since December 15, 2017
No. of Shareholders: 54,353
No. of Employees: 2,421
Sector Healthcare
Industry Healthcare Providers & Services
Exchange National Stock Exchange of India
Shares in Issue 108,009,770
Free Float (0.0%)
Eligible for
SHALBY Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SHALBY
Upcoming Events for SHALBY
Frequently Asked Questions for Shalby
What is the Shalby share price?

As of 3:45am, shares in Shalby are trading at ₹107.35, giving the company a market capitalisation of £115.9m. This share price information is delayed by 15 minutes.

How has the Shalby share price performed this year?

Shares in Shalby are currently trading at ₹107.35 and the price has moved by 22.12% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Shalby price has moved by -5.09% over the past year.

What are the analyst and broker recommendations for Shalby?

Of the analysts with advisory recommendations for Shalby, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Shalby is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Shalby next release its financial results?

Shalby is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Shalby dividend yield?

The Shalby dividend yield is 0.46% based on the trailing twelve month period.

Does Shalby pay a dividend?

Last year, Shalby paid a total dividend of 0.5, and it currently has a trailing dividend yield of 0.46%. Looking ahead, Shalby has not announced an ex-dividend date yet.

When does Shalby next pay dividends?

Shalby has yet to annouce their ex-dividend date. The historic dividend yield on Shalby shares is currently 0.46%.

How do I buy Shalby shares?

To buy shares in Shalby you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Shalby?

Shares in Shalby are currently trading at ₹107.35, giving the company a market capitalisation of £115.9m.

Where are Shalby shares listed? Where are Shalby shares listed?

Here are the trading details for Shalby:

Country of listing: India
Exchange: NSI
Ticker Symbol: SHALBY
What kind of share is Shalby?

Based on an overall assessment of its quality, value and momentum, Shalby is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Shalby share price forecast 2021?

Shares in Shalby are currently priced at ₹107.35. At that level they are trading at 27.45% discount to the analyst consensus target price of 0.00.

Analysts covering Shalby currently have a consensus Earnings Per Share (EPS) forecast of 4.45 for the next financial year.

How can I tell whether the Shalby share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shalby. Over the past six months, the relative strength of its shares against the market has been -5.1%. At the current price of ₹107.35, shares in Shalby are trading at 22.73% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Shalby PE Ratio?

The Shalby PE ratio based on its reported earnings over the past 12 months is 76.33. The shares are currently trading at ₹107.35.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Shalby?

Shalby's management team is headed by:

Vikram Shah - CHM
Darshini Shah - NED
Shyamal Joshi - NED
Tej Malhotra - NID
Shantilal Kothari - CFO
Shanay Shah - OTH
Jayesh Patel - CCO
Kunwar Sehgal - OTH
Shalinder Madhok - CIO
Nishita Shukla - OTH
Amit Chauhan - OTH
Babu Thomas - CHO
Chittaranjan Tripathy - VPR
Sujana Shah - IND
Ashok Bhatia - NED
Who are the major shareholders of Shalby?

Here are the top five shareholders of Shalby based on the size of their shareholding:

Shah (Vikram Indrajit) Individual Investor
Percentage owned: 47.72% (51.1m shares)
Zodiac Mediquip Ltd Corporation
Percentage owned: 29.48% (31.5m shares)
Shah (Darshini Vikram) Individual Investor
Percentage owned: 2.82% (3.01m shares)
Bellevue Asset Management AG Investment Advisor
Percentage owned: 0.24% (260k shares)
Lacuna Asia Pacific Health Mutual Fund
Percentage owned: 0.24% (260k shares)
Similar to SHALBY
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.